2024 Overview of Insulin Glargine Biosimilars
Insulin glargine, a long-acting insulin analog, is essential in diabetes management, offering reliable glucose control for up to 24 hours. As diabetes rates rise globally, insulin glargine biosimilars present a cost-effective alternative to branded options like Sanofi’s Lantus, helping to alleviate the financial burden